안과 요법을 향상시키기 위한 맞춤형 안과 서비스

안과학

Strong connections with Patient Advocacy Groups: trials designed with patients in mind.

Experience in working with ophthalmology sites to improve efficiency and protocol compliance.

Relationships with specialized vendors for ocular services: the right tools for your trial.

Experience matters when choosing a partner.

의사 결정에 있어 환자의 요구 사항을 우선시하는 동시에 안과학 연구를 확실하게 성공시키려면 경험이 중요합니다. Fortrea가 지닌 전문성과 통찰력은 신흥 및 중견 생명 공학 업체들에 유연한 솔루션을 제공하면서 지난 5년 동안 110건 이상의 임상 안과학 연구를 향상시키는 데 도움을 주었습니다.

In the last 5 years

We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers in the advancement of their ophthalmology therapies and supported:

114

Ophthalmology Studies

1,993

Sites

12,616명

환자

Our top areas of ophthalmology expertise:

Anterior Indications such as:

  • Glaucoma
  • Dry Eye Disease
  • Refractive Errors
  • Blepharitis

Posterior Indications such as:

  • Macular Degeneration
  • Rare Retinal Diseases
  • Retinopathy
  • Uveitis

Why choose Fortrea for your next Ophthalmology trial?

  • Experience as an industry leader gives us context to not just listen, but hear and respond to your needs 
  • Understanding of how to minimize site burden, to give your trial a competitive edge
  • A suite of tools to improve the patient and caregiver experience during your trial
  • Experienced team members, and our in-house Ophthalmology Academy gives us a pipeline of trained CRAs, PMs, and CTLs
  • Industry presence, including participation with Ocular Disease Forum, Mary Tyler Moore, RareX Vision Consortium focusing on the need for new endpoints.

세포 및 유전자 치료 Rare Diseases 모바일 임상 서비스

Get to know us

From working on over 100 ophthalmology studies in just the last 5 years alone, we understand the importance of a personalized approach to the unique challenges of ophthalmology including cell & gene therapies. We’re setting our teams up for success so they can successfully deliver life changing trials for patients with vision loss.

-Tanya Richardson, Executive Director & Global Lead, Strategic Delivery & Growth, Ophthalmology, Fortrea

강력한 환자 모집, 참여 및 유지를 통해 연구를 추진합니다.

각 안구 질환 적응증에 맞는 전략을 포함한 Fortrea의 총체적 접근 방식은 각 연구를 위한 가장 강력하고 가장 좋은 성과를 낼 수 있는 사이트를 찾기 위해 사이트와의 굳건한 관계에서 시작되며, 기존 계약을 활용하여 실험 착수를 촉진합니다. 당사의 주제별 전담 전문가 팀은 이전 및 현행 안과학 실험 경험에서 수집한 모범 사례를 통합하는 포괄적인 데이터 중심의 현장 및 환자 참여 전략을 제공합니다.

Your partner for comprehensive ophthalmology clinical trials.

Once your trial is underway, you can rely on Fortrea’s ocular clinical trial management team to provide close communication and collaboration. We work to identify certified vendors that perform visual acuity assessments and central reads of ocular imaging. We also use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

Fortrea has the tools to help improve health and lives by bringing vision treatments to market quickly and carefully.

 

최신 소식 받기:
Fortrea 뉴스 및 공지사항을 구독하세요.